Amneal Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Amneal Pharmaceuticals's balance sheet done over the years? Its assets were worth $3,472,569,000 last year, which is less than in the previous period. 99% of Amneal Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $3,452,788,000, which means an decrease by -4% compared compared to last year.
Debt to Assets
| 2015 | 1014093000 | 1.20B | 118.43% |
|---|---|---|---|
| 2016 | 1218817000 | 1.39B | 114.44% |
| 2017 | 1341889000 | 1.71B | 127.99% |
| 2018 | 4352736000 | 3.45B | 79.41% |
| 2019 | 3665890000 | 3.31B | 90.54% |
| 2020 | 4006033000 | 3.66B | 91.39% |
| 2021 | 3939664000 | 3.57B | 90.69% |
| 2022 | 3799341000 | 3.59B | 94.5% |
| 2023 | 3472569000 | 3.45B | 99.43% |
AMRX Balance Sheet (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||
Current assets: | |||||||||
Cash and cash equivalents | 91.54M | 25.97M | 247.79M | 341.37M | 151.19M | 213.39M | 74.16M | 27.36M | 61.08M |
Short term investments | 2.2M | 1.82M | 1.17M | 1.69M | 1.12M | 2.14M | 1.85M | 4.35M | 4.97M |
Net receivables | 613.73M | 742.29M | 663.76M | 640.30M | 606.15M | 482.32M | 351.36M | 394.78M | 273.83M |
Inventory | 581.38M | 530.73M | 489.38M | 490.64M | 381.06M | 457.21M | 284.03M | 266.16M | 234.96M |
Other current assets | 91.20M | 103.56M | 110.21M | 73.46M | 70.16M | 128.32M | 62.36M | 33.44M | 29.74M |
Total current assets | 1.37B | 1.41B | 1.52B | 1.55B | 1.21B | 1.28B | 771.93M | 726.11M | 604.60M |
Non-current assets: | |||||||||
Property, Plant and Equipment | 550.13M | 589.36M | 639.00M | 595.16M | 609.15M | 544.14M | 486.75M | 407.40M | 318.82M |
Goodwill | 598.62M | 598.85M | 593.01M | 522.81M | 419.50M | 426.22M | 26.44M | 28.44M | 29.82M |
Intangible assets | 890.42M | 1.09B | 1.16B | 1.30B | 1.38B | 1.65B | 44.59M | 45.92M | 49.69M |
Long term investments | 37.08M | 85.58M | 0 | 0 | 16.37M | 0 | 0 | 0 | 0 |
Other non-current assets | 18.42M | 103.21M | 20.61M | 31.88M | 44.27M | 67.59M | 11.25M | -481.77M | -398.33M |
Total non-current assets | 2.09B | 2.38B | 2.41B | 2.45B | 2.45B | 3.06B | 569.95M | 481.77M | 398.33M |
Total assets | 3.47B | 3.79B | 3.93B | 4.00B | 3.66B | 4.35B | 1.34B | 1.21B | 1.01B |
Liabilities | |||||||||
| Current liabilities: | |||||||||
Accounts payable | |||||||||
Deferred revenue | 0 | 0 | 0 | 0 | 0 | 17.42M | 137.07M | 0 | 0 |
Short term debt | 227.62M | 104.63M | 46.03M | 55.68M | 36.95M | 21.71M | 89.48M | 0 | 59.68M |
Total current liabilities | 846.59M | 752.8M | 677.24M | 676.90M | 550.40M | 553.85M | 296.88M | 225.07M | 239.14M |
| Non-current liabilities: | |||||||||
Long term debt | 2.52B | 2.74B | 2.83B | 2.88B | 2.72B | 2.66B | 1.39B | 1.15B | 952.63M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 41.77M | 97.11M | 65.42M | 99.07M | 39.58M | 231.66M | 10.28M | -1.15B | -1.01M |
Total non-current liabilities | 2.56B | 2.83B | 2.89B | 2.98B | 2.76B | 2.90B | 1.42B | 1.15B | 951.62M |
Total liabilities | 3.45B | 3.59B | 3.57B | 3.66B | 3.31B | 3.45B | 1.71B | 1.39B | 1.20B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |